May drug-related cardiovascular toxicities persist after hospital discharge in COVID-19 patients?

Int J Antimicrob Agents. 2020 Jun;55(6):106003. doi: 10.1016/j.ijantimicag.2020.106003. Epub 2020 Apr 30.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiviral Agents / adverse effects*
  • Antiviral Agents / therapeutic use*
  • Betacoronavirus / drug effects
  • COVID-19
  • Cardiotoxicity
  • Cardiovascular Diseases / chemically induced*
  • Coronavirus Infections / drug therapy*
  • Humans
  • Pandemics
  • Patient Discharge
  • Pneumonia, Viral / drug therapy*
  • SARS-CoV-2

Substances

  • Antiviral Agents

Supplementary concepts

  • COVID-19 drug treatment